Musk: Posts Drug Test Results, Challenges New York Times

Go to Article

New York Times was quick to throw accusations at Elon Musk, saying he was on drugs.

I don’t think they expected this.

Musk then took a drug test.

Once the results came in, he took a pic of the official form and blasted it out for the world to see.

People are saying this is lawsuit time against New York Times.

The Post Millennial reports:

Elon Musk shared the results of a negative drug test on Tuesday after a recent New York Times report alleged that the billionaire mogul had been abusing several drugs while on President Donald Trump’s 2024 campaign trail.

The Times report claimed that Musk was frequently consuming ketamine, ecstasy, and magic mushrooms, citing people familiar with the matter. However, the allegations appeared to be false, according to a June 11 lab test that showed the SpaceX CEO to be drug-free.

The drug test was conducted by “Fastest Labs of South Austin” in Texas, according to a screenshot of the results that Musk shared on X, which included an added caption that stated: “lol.”

The test results became available five days after Musk provided his urine sample. It showed negative results for ecstasy, amphetamines, cocaine, ketamine, fentanyl, cannabinoids, and others. According to the results, Musk did not test positive for any drugs in his system.

Musk previously refuted the drug allegations reported by the New York Times, stating, “I tried *prescription* ketamine a few years ago and said so on X, so this is not even news. It helps for getting out of dark mental holes but haven’t taken it since then.” The DOGE head then accused the paper of “lying.”

According to the Times report, Musk was a “chronic” ketamine user who suffered from bladder difficulties. Sources further alleged that he maintained a stash of narcotics in a daily medicine pill box that could carry approximately 20 pills.

The legacy media apparently thinks they won’t get caught in their lies.

Now they’ve been challenged to take a drug test too.



Comment on this Article Via Your Disqus Account